Answers are grounded in this paper and cite their sources.
Purpose: The purpose of this study was to examine the efficacy of modified constraint-induced movement therapy (mCIMT), which was applied to lower extremity, on strength and quality of life in patients with stroke. Methods: 30 patients with stroke were randomized to 2 groups. Both groups received first neurodevelopmental therapy (NDT) for 4 weeks as baseline treatment following which the study group received mCIMT and the control group received NDT for 2 weeks as experimental treatment. All were evaluated 3 times (pre-baseline treatment, post-baseline treatment, post-experimental treatment) through Motricity Index (MI), Stroke Impact Scale (SIS) and Stroke Specific Quality of Life (SS-QoL) scale. Results: The total score, mobility, self-care, upper extremity function, thinking, mood, family and social roles subdomain scores of the SS-QoL significantly increased in the study group, particularly during the experimental treatment period (p < 0.05). The amount of perceived recovery domain of SIS was greater in the study group during both the experimental and total treatment periods (p = 0.000). Significant improvement was observed in paretic lower extremity strength only in the study group for the total treatment period (p = 0.029). Correlations between the total change of scores in strength and quality of life and the changes in the experimental treatment period were found strong. Conclusion: This study shows that mCIMT is more effective than NDT in patients with stroke to improve paretic lower extremity strength and health related quality of life.
No takes yet. Share an insight, caveat, or question.
Candan et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: